PH21873A - Vaccine for the treatment of urinary tract infections containing aluminum phosphate - Google Patents

Vaccine for the treatment of urinary tract infections containing aluminum phosphate

Info

Publication number
PH21873A
PH21873A PH32723A PH32723A PH21873A PH 21873 A PH21873 A PH 21873A PH 32723 A PH32723 A PH 32723A PH 32723 A PH32723 A PH 32723A PH 21873 A PH21873 A PH 21873A
Authority
PH
Philippines
Prior art keywords
urinary tract
vaccine
aluminum phosphate
tract infections
treatment
Prior art date
Application number
PH32723A
Other languages
English (en)
Inventor
Llubinko Stojkovic
Rodmila Pavic
Vera Spasojevic
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of PH21873A publication Critical patent/PH21873A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0266Klebsiella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/852Klebsiella
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/873Proteus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH32723A 1984-08-31 1985-08-30 Vaccine for the treatment of urinary tract infections containing aluminum phosphate PH21873A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4181/84A CH664497A5 (de) 1984-08-31 1984-08-31 Vakzine zur behandlung der harnwegsinfektionen.

Publications (1)

Publication Number Publication Date
PH21873A true PH21873A (en) 1988-03-25

Family

ID=4271298

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32723A PH21873A (en) 1984-08-31 1985-08-30 Vaccine for the treatment of urinary tract infections containing aluminum phosphate

Country Status (16)

Country Link
US (1) US4606919A (fr)
EP (1) EP0173241B1 (fr)
JP (1) JPS6160618A (fr)
KR (1) KR890004019B1 (fr)
AT (1) ATE65409T1 (fr)
CA (1) CA1252722A (fr)
CH (1) CH664497A5 (fr)
DE (1) DE3583562D1 (fr)
DK (1) DK397085A (fr)
ES (1) ES8700939A1 (fr)
MX (1) MX7573E (fr)
PH (1) PH21873A (fr)
PL (1) PL145565B1 (fr)
PT (1) PT81063B (fr)
SU (1) SU1452462A3 (fr)
ZA (1) ZA856675B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
IT1199301B (it) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
US6099853A (en) * 1997-09-04 2000-08-08 Protein Express Vaginal suppository vaccine for urogenital infections
US7135191B2 (en) 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
DE19933094A1 (de) 1999-07-15 2001-01-18 Herberts Gmbh & Co Kg Pigmentpasten, deren Herstellung und diese enthaltende kathodisch abscheidbare Überzugsmittel
AU2001264669A1 (en) * 2000-05-22 2001-12-03 Xin Li Proteus mirabilis-based vaccine
JP4672743B2 (ja) 2008-03-01 2011-04-20 株式会社東芝 誤り訂正装置および誤り訂正方法
WO2010124085A2 (fr) * 2009-04-23 2010-10-28 Cornell University Compositions et méthodes pour prévenir et traiter une maladie utérine
EP2872535A1 (fr) 2012-07-16 2015-05-20 Pfizer Inc. Saccharides et leurs utilisations
UA125901C2 (uk) * 2018-12-27 2022-07-06 Ігор Семенович Марков Ешерихіозно-ентерококова інактивована рідка вакцина проти кишкової палички та ентерокока, спосіб її виготовлення та спосіб лікування і профілактики нею

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183161A (en) * 1955-05-02 1965-05-11 Parke Davis & Co Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
US3501770A (en) * 1967-04-13 1970-03-17 Lilly Co Eli Shipping fever vaccine
US3634198A (en) * 1968-02-27 1972-01-11 Andrew Truhan Detection of urinary tract infections
FR7461M (fr) * 1968-06-19 1970-01-05
FR2397839A1 (fr) * 1977-07-18 1979-02-16 Grimberg Georges Compose donnant un vaccin oral intestinal
US4298597A (en) * 1979-09-04 1981-11-03 University Of Saskatchewan Vaccine for diarrhea caused by E. coli
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
EP0048881B1 (fr) * 1980-09-15 1985-08-28 Bactex Incorporated Immunisation d'êtres humains contre une infection entérotoxogénique due à escherichia coli

Also Published As

Publication number Publication date
EP0173241A3 (en) 1988-07-27
KR870002254A (ko) 1987-03-30
MX7573E (es) 1989-11-09
DK397085A (da) 1986-03-01
PL145565B1 (en) 1988-10-31
ES546584A0 (es) 1986-11-16
ATE65409T1 (de) 1991-08-15
CH664497A5 (de) 1988-03-15
ZA856675B (en) 1986-04-30
EP0173241B1 (fr) 1991-07-24
DK397085D0 (da) 1985-08-30
ES8700939A1 (es) 1986-11-16
PT81063B (pt) 1988-01-22
EP0173241A2 (fr) 1986-03-05
KR890004019B1 (ko) 1989-10-16
DE3583562D1 (de) 1991-08-29
JPS6160618A (ja) 1986-03-28
SU1452462A3 (ru) 1989-01-15
CA1252722A (fr) 1989-04-18
PL255193A1 (en) 1986-07-15
PT81063A (en) 1985-09-01
US4606919A (en) 1986-08-19

Similar Documents

Publication Publication Date Title
PH21873A (en) Vaccine for the treatment of urinary tract infections containing aluminum phosphate
EP0217580A3 (fr) Nucléosides thérapeutiques
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
MY120501A (en) Micro-encapsulated lactobacilli for medical applications
EP0772439A4 (fr) Nouveaux composes antibiotiques et procedes de traitement d'infections a bacteries gram positif et a mycoplasmes
Thornhill et al. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic
PL339075A1 (en) Vaccine against genitourinary infections in the form of intravaginal suppositories
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
JPS57143000A (en) Antibiotic compound, manufacture and medical use
TW365538B (en) Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans
Salo et al. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema
Egede et al. A clinical comparative study of ofloxacin and pivampicillin in acute exacerbations of chronic bronchitis
FR2397839A1 (fr) Compose donnant un vaccin oral intestinal
McKendrick et al. Cefotaxime—a clinical study
Saltvedt et al. Pivmecillinam plus pivampicillin in urinary tract infections. A double-blind comparison with pivmecillinam alone in hospitalized patients
Orsolini et al. Synergistic Interaction of Cephalosporins and Human Serum on Gram-Negative Bacteria
Gouin et al. Treatment of bronchopulmonary infections with dibekacin.
TH3258EX (th) วัคซีนสำหรับใช้รักษาการติดเชื้อโรคในระบบทางเดินปัสสาวะ
Kushnareva et al. The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants
Fernandez Statistical Study of Infection of Surgical Wound.
Tkacz et al. A comparison of mezlocillin and carbenicillin with respect to efficacy and tolerance for the treatment of bacterial infections.
Geddes Antibiotic management of serious infections
Carbon Effectiveness of moxalactam in septicemias and focal infections. Results of the cooperative study carried out in France.
MY102905A (en) Therapeutic nucleosides
BG51860A1 (en) Formulation for peroral immunotherapy and immunoprophylaxy of the nonspecific infectious diseases of the urinary tract